Fate Therapeutics
+$0.23 (+0.27%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.
About FATE
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.
CEO
J. Scott Wolchko
Employees
279
Headquarters
San Diego, California
Founded
2007
FATE Key Statistics
Market Cap
8.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
772.68K
High Today
$86.79
Low Today
$83.30
Open Price
$85.67
Volume
680.71K
52 Week High
$121.16
52 Week Low
$29.37
Analyst Ratings
76%
of 17 ratings
Buy
76.5%
Hold
23.5%
Sell
0%
FATE Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 4, After Hours